Abnormal liver metabolism in cancer patients detected by 31P MR spectroscopy

NMR in Biomedicine

Volumn 12, Issue 8, 1999, Pages 535-544

  Dagnelie, Pieter C ^a,b,c   Sijens, Paul E ^c   Kraus, Deni J A ^d   Planting, André S Th ^c   Van Dijk, Pieter ^c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d Drechtsteden Ziekenhuis   (Netherlands)

Author keywords

Cancer; Gluconeogenesis; Glucose metabolism; Liver metabolism; Magnetic resonance spectroscopy

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; FRUCTOSE 6 PHOSPHATE; GLUCOSE 6 PHOSPHATE; GLYCERALDEHYDE 3 PHOSPHATE; GLYCEROPHOSPHATE; PHOSPHATE; PHOSPHOETHANOLAMINE; PHOSPHORYLCHOLINE;

ARTICLE; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; LIVER METABOLISM; LUNG CANCER; METASTASIS; PH; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; GLUCONEOGENESIS; GLUCOSE; HUMANS; HYDROGEN-ION CONCENTRATION; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASMS; PHOSPHATES;

EID: 0033366956     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199912)12:8<535::AID-NBM601>3.0.CO;2-1     Document Type: Article

References (47)

1. Lawson, D. H., Richmond, A., Nixon, D. W. and Rudman, D. Metabolic approaches to cancer cachexia. Annu. Rev. Nutr. 2, 277-301 (1982).
2. Kern, K. A. and Norton, J. A. Cancer cachexia. J. Parent. Ent. Nutr. 12, 286-298 (1988).
3. Rossi-Fanelli, F., Cascino, A. and Muscaritoli, M. Abnormal substrate metabolism and nutritional strategies in cancer management. J. Parent. Ent. Nutr. 15, 680-683 (1991).
4. Greenberg, E., Divertie, M. B. and Woolnet, L. B. A review of unusual systemic manifestations associated with carcinoma. Am. J. Med. 36, 106-120 (1964).
5. Heymsfield, S. B. and McManus, C. B. Tissue components of weight loss in cancer patients, a new method of study and preliminary observations. Cancer 55, 238-249 (1985).
6. Walsh, P. N. and Kissane, J. M. Nonmetastatic hypernephroma with reversible hepatic dysfunction. Arch. Intern. Med. 122, 214-222 (1968).
7. Kurzer, M., Janiszewski, J. and Meguid, M. M. Amino acid profiles in tumor-bearing and pair-fed nontumor-bearing malnourished rats. Cancer 62, 1492-1496 (1988).
8. Herzfeld, A., Greengard, O. and McDermott, W. V. Enzyme pathology of the liver in patients with and without nonhepatic cancer. Cancer 45, 2383-2388 (1980).
9. Herzfeld, A. and Greengard, O. The effect of lymphoma and other neoplasms on hepatic and plasma enzymes of the host rat. Cancer Res. 37, 231-238 (1977).
10. Douglas, R. G. and Shaw, J. H. F. Metabolic effects of cancer. Br. J. Surg. 77, 246-254 (1990).
11. Heber, D., Byerly, L. O. and Chlebowski, R. T. Metabolic abnormalities in the cancer patient. Cancer 55, 225-229 (1985).
12. Koea, J. B. and Shaw, J. H. F. The effect of tumor bulk on the metabolic response to cancer. Ann. Surg. 215, 282-288 (1992).
13. Warren, R. S., Jeevanandam, M. and Brennan, M. F. Protein synthesis in the tumor-influenced hepatocyte. Surgery 98, 275-281 (1985).
14. Roh, M. S., Ekman, L. G., Jeevanandam, M. and Brennan, M. F. Elevated energy expenditure in hepatocytes from tumor-bearing rats. J. Surg. Res. 38, 407-415 (1985).
15. Argilés, J. M. and López-Soriano, F. J. The energy state of tumor-bearing rats. J. Biol. Chem., 266, 2978-2982 (1991).
16. 31P magnetic resonance spectroscopy study. Br. J. Cancer 67, 1303-1309 (1993).
17. 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy. Br. J. Cancer 4, 953-958 (1991).
18. 31P chemical shift imaging of the human liver. Magn. Reson. Imag. 13, 621-628 (1995).
19. 31P-NMR spectroscopy. Biochim. Biophys. Acta 885, 1-11 (1986).
20. Oberhaensli, R. D., Galloway, G. J., Taylor, D. J., Bore, P. J., Rajagopalan, B. and Radda, G. K. First year of experience with P-31 magnetic resonance studies of human liver. Magn. Reson. Imag. 4, 413-416 (1986).
21. Cox, I. J., Sargentoni, J., Calam, J., Bryant, D. J. and Iles, R. A. Four-dimensional phosphorus-31 chemical shift imaging of carcinoid metastases in the liver. NMR Biomed. 1, 56-60 (1988).
22. 31P MRS. Invest. Radiol. 24, 980-984 (1990).
23. Oberhaensli, R. D., Rajagopalan, B., Galloway, G. J., Taylor, D. J. and Radda, G. K. Study of human liver disease with P-31 magnetic resonance spectroscopy. Gut 31, 463-467 (1990).
24. 31P magnetic resonance spectroscopy. NMR Biomed. 3, 17-22 (1990).
25. Cox, I. J., Menon, D. K., Sargentoni, J., Bryant, D. J., Collins, A. G., Coutts, G. A., Iles, R. A., Bell, J. D., Benjamin, I. S., Gilbey. S., Hodgson, H. J. F. and Morgan, M. Y. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques. J. Hepatol. 14, 265-275 (1992).
26. Rajanayagam, V., Lee, R. R., Ackerman, Z., Bradley, W. G. and Ross, B. D. Quantitative P-31 MR spectroscopy of the liver in alcoholic cirrhosis. J. Magn. Reson. Imag. 2, 183-190 (1993),
27. 31P MRS study of patients with liver cirrhosis: progress towards a non-invasive assessment of disease severity. NMR Biomed. 6, 168-172 (1993).
28. Menon, D. K., Sargentoni, J., Taylor-Robinson, S. D., Bell, J. D., Cox, I. J., Bryant, D. J., Coutts, G. A., Rolles, K., Burroughs, A. K. and Morgan, M. Y. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology 21, 417-427 (1995).
29. 31P magnetic resonance spectroscopy in chronic alcohol abusers. Gastroenterology 108, 776-788 (1995).
30. Schneeberger, A. L., Thompson, R. T., Driedger, A. A., Finley, R. J., Inculet, R. I. Effect of cancer on the in vivo energy state of rat liver and skeletal muscle. Cancer Res. 49, 1160-1164 (1980).
31. Dagnelie, P. C., Bell, J. D., Williams, S. C. R., Bates, T. E., Abel, P. D. and Foster, C. S. Effect of fish oil on cancer cachexia and host liver metabolism in rats with prostate tumors. Lipids 29, 195-203 (1994).
32. Cox, I. J., Coutts, G. A., Gadian, D. G., Ghosh, P., Sargentoni, J. and Young, I. R. Saturation effects in phosphorus-31 magnetic resonace spectra of the human liver. Magn. Reson. Med. 17, 53-61 (1991).
33. 1-values. Magn. Reson. Med. 32, 137-141 (1994).
34. 31P MRS in vivo. Part II: muscle, liver, kidney. Magn. Reson. Med. 32, 453-458 (1994).
35. 1H-NMR investation in vitro of normal and abnormal human liver. Biochim. Biophys. Acta 1225, 71-77 (1993).
36. 31P-NMR spectroscopy. Biochim. Biophys. Acta 885, 1-11 (1986).
37. Waterhouse, C. Lactate metabolism in patients with cancer. Cancer 33, 66-7 (1974).
38. Heber, D., Byerly, L. O. and Chlebowski, R. T. Metabolic abnormalities in the cancer patient. Cancer 55, 225-229 (1985).
39. Edén, E., Edström, S., Bennegard, K., Scherstén, T. and Lundholm, K. Glucose flux in relation to energy expenditure in malnourished patients with and without cancer during periods of fasting and feeding. Cancer Res. 44, 1718-1724 (1984).
40. Holroyde, C. P., Gabuzda, T. G., Putnam, R. C., Paul, P. and Reichard, G. A. Altered glucose metabolism in metastatic carcinoma. Cancer Res. 35, 3710-3714 (1975).
41. Shaw, J. H. F., Humberstone, D. M. and Wolfe, R. R. Energy and protein metabolism in sarcoma patients. Ann. Surg. 207, 283-289 (1988).
42. Humberstone, D. A. and Shaw, J. H. F. Metabolism in hematologic malignancy. Cancer 62, 1619-1624 (1988).
43. Liu, K. J. M., Henderson, Th., Kleps, R., Reyes, M. C. and Nyhus, L. Gluconeogenesis in the liver of tumor rats. J. Surg. Res. 49, 179-185 (1990).
44. 13C NMR study of hepatic pyruvate carboxylase activity in tumor rats. Biochem. Biophys. Res. Commun. 179, 366-371 (1991).
45. 13C nuclear magnetic resonance study. Cancer Res. 55, 761-766 (1995).
46. 31P magnetic resonance spectroscopy of focal hepatic malignancies. NMR Biomed. 5, 114-120 (1992).
47. Stubbs, M., Veech, R. L. and Griffiths, J. R. Tumor metabolism: the lessons of magnetic resonance spectroscopy. Adv. Enzyme Regul. 35, 101-115 (1995).